ID | 1385 | |
PMID | 20089796 | |
Year | 2010 | |
Sequence | NKSLGACPIRTQPRW NYYDSFSAVSEDNLGF | |
Name | HSV-1 gD 121-152 (group-1) | |
Length | 32 | |
N-Terminal Modification | Free | |
C-Terminal Modification | Free | |
Linear/ Cyclic | Linear | |
Chirality | L | |
Chemical Modification | None | |
Origin of Peptide | T-cell epitope peptide identified from HSV1-gD | |
Nature of Peptide/Cargo | Intranasal aministration of HSV-gD peptides plus CpG can induce local ocular mucosal and systemic T-cell responses | |
Mechanism | Not mentioned | |
Cargo Sequence/Structure | None | |
Name of cargo | Not applicable | |
Assay | FACS | |
Enhancer | CpG adjuvant | |
Properties of enhancer | Not mentioned | |
Concentration | 50 µl per nasal cavity | |
Incubation time | Immunized on 0,14 and 21 days. Euthanized after 10 days. | |
Tissue permeability (value with units) | Detectable HSV-1-specific CD4+ T cell responses were induced at the local (conjunctiva) and systemic (spleen) levels | |
Tissue Sample | Nasal cavity of New Zealand White rabbits | |
Ex vivo/In vivo/In vitro | in vivo | |
STRUCTURE |
| |
SMILES | N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O) N[C@H]([C@H](O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C=O) Cc3ccccc3)CC(C)C)CC(=O)N)CC(=O)O)CCC(=O)O)CO)C(C)C)C)CO)Cc3ccccc3)CO) CC(=O)O)Cc3ccc(cc3)O)Cc3ccc(cc3)O)CC(=O)N)Cc3c[nH]c4c3cccc4)CCCNC(=N)N)CCC2)CCC(=O) N)[C@H](O)C)CCCNC(=N)N)[C@H](CC)C)CCC1)CS)C)CC(C)C)CO)CCCCN)CC(=O)N |